We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Explainer on product information templates to be used by applicants and Marketing Authorisation Holders (MAHs) of veterinary medicines.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
Guidance on Conditional Marketing Authorisations, exceptional circumstances Marketing Authorisations and national scientific advice
If the UKCA marking applies to products you manufacture or supply, you will have specific obligations and responsibilities for compliance, depending on your role.
Resources to help anyone developing or running a digital health product to conduct an evaluation.
How to use a cost effectiveness analysis to evaluate your digital health product.
How to use focus groups to evaluate your digital health product.
The UK government's design principles and examples of how they've been used.
What animal by-products (ABPs) are, how to set up a site that uses them safely, the paperwork you need, and how to dispose of them.
The guide, toolkit and further information for GB authorities with responsibility for consumer product safety.
How to comply with the requirements on promoting medicines to the public and to prescribers and suppliers of medicines.
How to use a randomised controlled trial to evaluate your digital health product.
Resources for local regulators.
An overview of the work the IPO is undertaking in relation to Standard Essential Patents.
Find out about the legal definitions of biofuel products, excise duty rates and the roles and responsibilities of producers from 1 April 2022.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
How to submit your periodic safety update report report (PSUR) or periodic benefit risk evaluation report (PBRER)
Advice on writing clear notices and maximising replies to your FSNs.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).